Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.070
+0.020 (1.90%)
At close: Dec 20, 2024, 4:00 PM
1.050
-0.020 (-1.88%)
After-hours: Dec 20, 2024, 7:20 PM EST
Adial Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Selling, General & Admin | 5.36 | 5.62 | 8.91 | 9.3 | 5.07 | 4.28 | |
| Research & Development | 2.76 | 1.27 | 1.95 | 8.4 | 5.85 | 3.97 | |
| Operating Expenses | 8.13 | 6.89 | 10.86 | 17.69 | 10.93 | 8.24 | |
| Operating Income | -8.13 | -6.89 | -10.86 | -17.69 | -10.93 | -8.24 | |
| Interest & Investment Income | 0.14 | 0.07 | 0.06 | 0.01 | 0.03 | 0.1 | |
| Earnings From Equity Investments | -0.19 | -0.19 | - | - | - | - | |
| Other Non Operating Income (Expenses) | 0.06 | 0.01 | - | 0.02 | 0 | - | |
| EBT Excluding Unusual Items | -8.12 | -7 | -10.8 | -17.67 | -10.89 | -8.15 | |
| Merger & Restructuring Charges | - | - | - | -0.05 | - | - | |
| Asset Writedown | - | - | - | -1.55 | - | - | |
| Other Unusual Items | -4.46 | - | - | -0.25 | - | -0.44 | |
| Pretax Income | -13.03 | -7 | -10.8 | -19.52 | -10.89 | -8.59 | |
| Income Tax Expense | - | - | - | -0.09 | - | - | |
| Earnings From Continuing Operations | -13.03 | -7 | -10.8 | -19.42 | -10.89 | -8.59 | |
| Earnings From Discontinued Operations | -0.02 | 1.88 | -1.94 | - | - | - | |
| Net Income | -13.05 | -5.12 | -12.73 | -19.42 | -10.89 | -8.59 | |
| Net Income to Common | -13.05 | -5.12 | -12.73 | -19.42 | -10.89 | -8.59 | |
| Shares Outstanding (Basic) | 4 | 1 | 1 | 1 | 0 | 0 | |
| Shares Outstanding (Diluted) | 4 | 1 | 1 | 1 | 0 | 0 | |
| Shares Change (YoY) | 248.81% | 42.25% | 34.69% | 49.15% | 26.50% | 107.01% | |
| EPS (Basic) | -3.41 | -3.60 | -12.71 | -26.12 | -21.85 | -21.80 | |
| EPS (Diluted) | -3.41 | -3.60 | -12.71 | -26.12 | -21.85 | -21.80 | |
| Free Cash Flow | -6.69 | -6.81 | -11.19 | -12.01 | -7.63 | -6.34 | |
| Free Cash Flow Per Share | -1.75 | -4.78 | -11.17 | -16.16 | -15.31 | -16.08 | |
| EBITDA | -8.13 | -6.89 | -10.86 | -17.69 | -10.93 | -8.24 | |
| D&A For EBITDA | 0 | 0 | 0 | 0.01 | 0 | 0 | |
| EBIT | -8.13 | -6.89 | -10.86 | -17.69 | -10.93 | -8.24 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.